407 In contrast, the ATTRACTION-4 trial, which investigated nivolumab plus SOX or CAPOX in gastric/EGJ cancer, met its PFS endpoint (HR = 0.68, P = 0.0007) but did not demonstrate a statistically significant improvement in OS (HR = 0.90, P = 0.26), potentially influenced by high rates of subsequent therapy, including ICIs, in the control arm
[...] Rated 5 out of 5 Leon Fat burning is real
Potential Side Effects PT-141 may cause side effects
Nonetheless, the study highlights a potential safety signal that warrants further investigation
Either drug should be used along with other measures, such as diet and exercise, per medical advice from your healthcare provider